These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2180660)

  • 1. Blood or urine glucose-based insulin therapy and control of glycemia. Computer-simulation study.
    Albisser AM; Sozzi S; Strack TR
    Diabetes Care; 1990 Apr; 13(4):393-400. PubMed ID: 2180660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted insulin dosage adjustment.
    Schiffrin A; Mihic M; Leibel BS; Albisser AM
    Diabetes Care; 1985; 8(6):545-52. PubMed ID: 3908025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of diabetics with the use of a microprocessor: comparison of insulin treatments based on blood and urine glucose levels.
    Hermányi I; Tamás G
    Acta Diabetol Lat; 1988; 25(1):33-40. PubMed ID: 3043988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance in microcomputer-assisted conventional insulin therapy: computer simulation study results.
    Sozzi S; Strack T; Schulz M; Albisser AM
    Am J Physiol; 1988 Feb; 254(2 Pt 1):E237-42. PubMed ID: 3279805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does the renal threshold change? Insulin therapy, based on urine glucose concentration, controlled by a dosage-measuring computer].
    Hermányi I; Deutsoh T; Tamás G
    Orv Hetil; 1989 Jun; 130(24):1269-72. PubMed ID: 2671856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of urine glucose measurements for estimating plasma glucose concentration.
    Hayford JT; Weydert JA; Thompson RG
    Diabetes Care; 1983; 6(1):40-44. PubMed ID: 6341014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments.
    Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2018 Jun; 65(6):1281-1290. PubMed ID: 28866479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
    Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
    Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.
    Toffanin C; Visentin R; Messori M; Palma FD; Magni L; Cobelli C
    IEEE Trans Biomed Eng; 2018 Mar; 65(3):479-488. PubMed ID: 28092515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preprogrammed intravenous insulin infusion in diabetic humans: metabolic consequences of altering meal size.
    Levy-Marchal C; Perlman K; Zinman B; Albisser AM
    Diabetes Care; 1986; 9(3):283-90. PubMed ID: 3525058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
    Kovatchev BP; Patek SD; Ortiz EA; Breton MD
    Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.